Last reviewed · How we verify
Aspirin 325mg
Aspirin 325mg, developed by the University of Utah, is a marketed drug with a well-established presence in the pharmaceutical market. The key composition patent is set to expire in 2028, providing a significant period of market exclusivity. The primary risk is the potential increase in competition following the patent expiry.
At a glance
| Generic name | Aspirin 325mg |
|---|---|
| Also known as | ASA, Aspirin, Bayer, Salicylic acid, Acetylsalicylic acid |
| Sponsor | University of Utah |
| Drug class | Nonsteroidal Anti-inflammatory Drug [EPC] |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Trial to Determine Effective Aspirin Dose in COPD (PHASE3)
- Body Weight, Aspirin Dose and Pro-resolving Mediators (PHASE4)
- Stroke Rate in Patients With Blunt Cerebrovascular Injury (BCVI) Treated With Oral Acetylsalicylic Acid (ASA) 81 mg Versus ASA 325 mg (BASA). (PHASE4)
- The Accuracy Of A Novel Platelet Activity Assay In Humans On Antiplatelet Agents: Pharmacodynamics And Comparison With Light Transmission Aggregometry (EARLY_PHASE1)
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG (PHASE3)
- Using Aspirin to Improve Immunological Features of Ovarian Tumors (EARLY_PHASE1)
- Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Subjects (PHASE1)
- Study of Aspirin in Patients With Vestibular Schwannoma (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Aspirin 325mg CI brief — competitive landscape report
- Aspirin 325mg updates RSS · CI watch RSS
- University of Utah portfolio CI